Saturday 17 October 2026 Export CCM’s income statement to Excel — free account

Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $65.9 million, up 25.2% from fiscal 2024.

3.63 0.08 −2.16%

Follow CCM

Alert me

Market cap: $10.5M
P/E: 0.0×
Fwd P/E: −4.4×
Dividend yield: —
F-score: 6/9
Altman Z: −1.20
Beneish M: −5.04
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 45.88%

Capital & Financial Ratios $m

Market Cap 10.46

Revenue 155.78

Net Income (53.70)

Free Cash Flow 67.56

Net Debt 395.45

Current Ratio 0.42

Debt/Equity 1.76

P/E ratio 0.00

Fwd P/E (4.39)

P/S ratio 0.10

P/B ratio 0.07

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth —

Next Y revenue growth (100.00%)

Next 5Y EPS Growth 20.00%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.92%

10-year low 10-year high

P/B against its own 10 years 2.02%

10-year low 10-year high

EV/Sales against its own 10 years 51.35%

10-year low 10-year high

EV/FCF against its own 10 years 65.28%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2020	Powerpack
2019	Powerpack
2018	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2022	2023	2024	2025
Cash	23	13	51	43
Receivables	19	10	7	6
Inventory	12	6	5	7
Other	—	—	—	—
	110	87	135	135

	2022	2023	2024	2025
Payables	21	18	27	17
ST’ Debt	50	102	52	79
Other	61	0	—	—
	163	275	291	279

Compound Annual Growth %

	10y	5y	3y
Sales	(3.62%)	14.02%	(1.28%)
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	1.80%	0.00%	(3.26%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	66
’24	—	—	—	—	53
’23	—	—	—	—	76
’22	—	—	—	—	68
’21	—	—	—	—	76
’20	—	—	—	—	34

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(29)
’24	—	—	—	—	(54)
’23	—	—	—	—	(39)
’22	—	—	—	—	(31)
’21	—	—	—	—	(56)
’20	—	—	—	—	(35)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(36)
’24	—	—	—	—	(111)
’23	—	—	—	—	(55)
’22	—	—	—	—	(63)
’21	—	—	—	—	(70)
’20	—	—	—	—	(62)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(3.04)
’24	—	—	—	—	(9.67)
’23	—	—	—	—	(9.60)
’22	—	—	—	—	(16.20)
’21	—	—	—	—	(29.40)
’20	—	—	—	—	(23.40)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	35.10	32.20	24.60	18.50	11.30	18.50	11.50	9.20	3.80	3.54	Analyst estimates 2026–2028 Powerpack
	High	51.30	49.60	42.00	36.00	58.90	47.00	23.80	19.90	26.70	10.77
People
People	Employees	739	583	584	738	851	972	918	727	595	610
	Revenue/emp, $m	0.09	0.09	0.05	0.04	0.04	0.08	0.07	0.10	0.09	0.11
Income, $m
Income, $m	Revenue	66	51	28	28	34	76	68	76	53	66
	Gross margin, %	37.03	29.61	10.35	(7.98)	5.87	(11.72)	(32.28)	(14.26)	(20.62)	5.61
	EBT	(29)	(39)	(33)	(56)	(68)	(83)	(122)	(78)	(92)	(53)
	EBT margin, %	(44.96)	(76.71)	(117.99)	(197.15)	(198.05)	(108.98)	(177.91)	(103.39)	(174.39)	(81.07)
	Net income	(38)	(44)	(38)	(51)	(62)	(82)	(111)	(75)	(89)	(54)
	Depreciation	19	15	8	8	12	16	19	18	18	21
Per share, $
Per share, $	Revenue	15.05	11.73	6.40	6.56	7.82	17.44	15.67	17.33	12.04	15.08
	Earnings	(8.70)	(10.20)	(12.00)	(18.30)	(23.40)	(29.40)	(16.20)	(9.60)	(9.67)	(3.04)
	Cash flow	(2.58)	0.95	(1.29)	(6.46)	(8.06)	(12.91)	(7.19)	(8.91)	(12.47)	(6.61)
	Capex	(2.25)	(1.75)	(1.74)	(5.42)	(6.17)	(3.08)	(7.25)	(3.77)	(12.89)	(1.60)
	Free cash flow	(4.83)	(0.80)	(3.03)	(11.89)	(14.23)	(15.99)	(14.44)	(12.68)	(25.36)	(8.21)
	Book value	40.74	35.98	18.56	(0.67)	(17.99)	(33.66)	66.90	56.33	50.74	60.57
	Shares, m	4	4	4	4	4	4	4	4	4	4
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	2.18	1.63	2.26	2.03	1.97	0.82	0.55	0.32	0.15	0.11
	P/B	0.93	0.70	2.46	0.00	0.00	0.00	0.00	0.18	0.09	0.07
	EV/Sales	1.74	1.20	2.39	6.45	7.00	4.53	3.60	2.57	2.51	2.65
	EV/FCF	2.39	1.64	2.45	5.52	6.34	7.23	7.70	5.92	5.79	6.10
Cash, $m
Cash, $m	Operating cash flow	(11)	4	(6)	(28)	(35)	(56)	(31)	(39)	(54)	(29)
	Capex	(10)	(8)	(8)	(24)	(27)	(13)	(32)	(16)	(56)	(7)
	Free cash flow	(21)	(3)	(13)	(52)	(62)	(70)	(63)	(55)	(111)	(36)
Balance, $m
Balance, $m	Working capital	35	0	52	(50)	25	(35)	(52)	(188)	(156)	(145)
	Total debt	79	99	79	192	321	367	408	383	422	431
	Net debt	(32)	(6)	(53)	176	265	342	385	370	371	389
	Shareholders’ equity	177	156	81	(3)	(79)	(147)	292	246	222	265
Returns, %
Returns, %	ROA	(7.39)	(8.76)	(8.71)	(12.36)	(14.31)	(14.35)	(7.68)	(4.87)	(4.76)	(1.43)
	ROIC	(10.42)	(13.52)	(99.09)	(22.69)	(16.25)	(23.05)	(7.02)	(6.62)	(7.69)	(3.58)
	ROE	(18.92)	(26.21)	(44.19)	(204.60)	251.88	114.14	(97.79)	(15.58)	(18.06)	(5.46)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Mar 2016

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CCEL Cryo-Cell International Inc.	$29.4M	— (loss-making)	43.8×	−0.02% (below 0%: shrinking)	+77.78% (above 0%: growing)	−58.37% (below 0%: shrinking)	79.38%	28.04%	Compare
DCGO DocGo Inc.	$27.9M	— (loss-making)	— (loss-making)	−8.70% (below 0%: shrinking)	n/m	−132.28% (below 0%: shrinking)	30.52%	(24.41%)	Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR	$15.9M	— (loss-making)	8.3×	+25,427.42% (above 0%: growing)	n/m	−206.36% (below 0%: shrinking)	42.70%	(1.24%)	Compare
CCM Concord Medical Services Holdings Limited	$10.5M	— (loss-making)	— (loss-making)	+37.65% (above 0%: growing)	n/m	−281.45% (below 0%: shrinking)	(13.15%)	0.00%
AMS American Shared Hospital Services	$8.4M	— (loss-making)	1.8×	+19.22% (above 0%: growing)	n/m	+195.82% (above 0%: growing)	17.00%	(7.22%)	Compare
CANOQ Cano Health, Inc.	$6.6M	— (loss-making)	—	−21.05% (below 0%: shrinking)	n/m	−43.68% (below 0%: shrinking)	100.00%	(16.23%)	Compare
MODVQ ModivCare Inc.	$6.2M	— (loss-making)	— (loss-making)	−3.18% (below 0%: shrinking)	n/m	−3,767.70% (below 0%: shrinking)	14.06%	(1.78%)	Compare
BMGL Basel Medical Group Ltd	$6.2M	—	—	—	—	—	—	—	Compare
RHEP Adcare Health Systems Inc	$5.2M	0.6×	— (loss-making)	+143.03% (above 0%: growing)	n/m	+224.45% (above 0%: growing)	31.50%	(0.88%)	Compare
Median of peers	$7.5M	—	8.3×	−0.02%	—	−58.37%	31.50%	(1.78%)

All 55 Medical Care Facilities stocks →